Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04445402 · ClinicalTrials.gov registry record
Pediatrics HOT COVID-19 Database in NY Tristate
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 77
- Enrollment target
NCT04445402 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 77 participants.
The verdict
NCT04445402 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
New York City (NYC) has become the epicenter of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). By collecting and summarizing the experience with other major health care providers in the tristate (New York (NY), New Jersey (NJ) and Connecticut (CT)) are, the investigators are uniquely positioned to inform the rest of the country about what to expect and how to manage children and young adults with hematological, oncological or stem cell transplant diagnoses during the pandemic.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2020-04-30 |
| Est. Completion | 2022-09-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04445402
The ClinicalTrials.gov registry entry for NCT04445402 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04445402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04445402 about?
NCT04445402 is a clinical study titled "Pediatrics HOT COVID-19 Database in NY Tristate". New York City (NYC) has become the epicenter of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). By collecting and summarizing the experience with other major health care providers in the tristate (New York (NY), New Jersey (NJ) and Connecticut (CT)) are...
What is the current status of trial NCT04445402?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2020-04-30. Estimated completion is 2022-09-12.
Who is sponsoring clinical trial NCT04445402?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.